|
|
Home sleep apnea testing compared to in-lab polysomnography for the evaluation of obstructive sleep apnea in children |
| 1R61HL162839-01 |
|
NHLBI |
2022 |
|
|
Treatment of Obstructive Sleep Apnea with Personalized Surgery in Children with Down Syndrome (TOPS-DS) |
| 1R61HL165345-01 |
|
NHLBI |
2022 |
|
|
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea |
| 1R61HL165366-01 |
|
NHLBI |
2022 |
|
|
Phenotypes and mechanisms of pulmonary hypertension-driven cognitive impairment and Alzheimers disease |
| 3R01HL154754-03S1 |
|
NHLBI |
2022 |
|
|
Positive Airway Pressure For The Treatment Of The Obstructive Sleep Apnea Syndrome In Children With Down Syndrome |
| 3R33HL151253-04S1 |
|
NHLBI |
2022 |
|
|
Medications for Obstructive Sleep Apnea to Improve Cognition in Children with Down Syndrome (MOSAIC DS) |
| 4R33HL151254-03 |
|
NHLBI |
2022 |
|
|
3D Models of the Blood-Brain Barrier for Studying Trauma-Induced Cerebral and Systemic Injuries |
| 4R33HL154250-03 |
|
NHLBI |
2022 |
|
|
Integrative metabolomic characterization of ADHD and asthma comorbidity |
| 5K01HL153941-03 |
|
NHLBI |
2022 |
|
|
Neurocognitive Impairment in Acute Respiratory Failure and Shock: Understanding the Role of Neuronal Excitotoxicity |
| 5K23HL140482-05 |
|
NHLBI |
2022 |
|
|
Sleep health in special populations |
| 5K24HL143055-05 |
|
NHLBI |
2022 |
